Press Releases

Amyris delivers high-performance alternatives to petroleum, plant and animal-based products across a wide range of consumer and industry segments. Our products offer customers a way to reduce environmental impact with No Compromise^® in performance or availability. We are making better chemistry biologically.

Investor Alerts

Mar 29, 2019

Amyris Delivers on First CBD Milestone; Earns $10 Million
Mar 27, 2019

Amyris to Present April 15 at Paradigm Capital Biosynthesis Conference – Exploring the Most Disruptive Technology in the Cannabis Industry
Mar 25, 2019

Amyris to Present at H.C. Wainwright Global Life Sciences Conference on April 8, 2019
Mar 18, 2019

Amyris Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Announces Signing of $300 Million Definitive Cannabinoid Agreement
Mar 18, 2019

Amyris Finalizes Cannabinoid Development, Licensing and Commercialization Agreement Containing $300 Million of R&D and Milestone Payments and a Long-Term Royalty Stream

LAVVAN Cites Amyris’s Proven Commercial Achievements and Capability to Bring to Market the Highest Quality Cannabinoids for Large Scale Use

Show per page

Beth Bannerman
Senior Vice President, Corporate Communications & Engagement
Amyris, Inc.
pr@amyris.com

Press Releases

Recent Tweets

Stay up to date